Abstract |
We have developed a simple and reliable procedure for determining serum levels of lipid-associated sialic acid ( LASA) in crude preparations. This method extracts essentially all gangliosides, excludes glycoprotein-bound sialic acid, and gives LASA values (0.5-1.0 mg/dL) in good agreement with values for isolated serum gangliosides. The procedure was used to determine serum levels of LASA in patients with colorectal cancer, in patients with nonmalignant diseases (pathological control subjects), and in normal control subjects. The results indicated that the percentages of total sialic acid ( TSA) comprised by LASA ( LASA/ TSA X 100) were elevated in patients with the earliest stages of colorectal cancer, compared with percentages in normal control subjects (P less than .001) and pathological control subjects (P less than .01).
|
Authors | C Tautu, G Verazin, J J Prorok, J A Alhadeff |
Journal | Journal of the National Cancer Institute
(J Natl Cancer Inst)
Vol. 80
Issue 16
Pg. 1333-7
(Oct 19 1988)
ISSN: 0027-8874 [Print] United States |
PMID | 3172258
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Gangliosides
- Lipids
- Sialic Acids
- N-Acetylneuraminic Acid
|
Topics |
- Adult
- Aged
- Colorectal Neoplasms
(blood, diagnosis)
- Female
- Gangliosides
(blood)
- Humans
- Lipids
(blood)
- Male
- Middle Aged
- N-Acetylneuraminic Acid
- Sialic Acids
(blood)
|